Clinical trial
Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs (Clinical Component of the RAMA Project)
NCT07093593 is registered in ClinicalTrials.gov with Centre Georges Francois Leclerc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs (Clinical Component of the RAMA Project)
- Lead sponsor
- Centre Georges Francois Leclerc
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2025
- Completion date
- September 1, 2032
- Enrollment
- 260 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancers, endometrial cancer, gynecological cancers, pancreatic adenocarcinoma, upper aerodigestive tract carcinoma